Tennessee’s supply of COVID-19 treatments to keep high-risk patients out of hospitals is rebounding following a period of scarcity during the omicron surge.
Officials from the Tennessee Department of Health said in a news release this week the state has seen an increase in its allocation of the two oral antiviral medications available to treat COVID-19 – Paxlovid by Pfizer and molnupiravir by Merck – since the first shipment of a combined 6,000 pills arrived Dec. 31.
“This increase in allocations is something we have been anticipating for weeks,” Dr. Lisa Pierce of the Tennessee Department of Health said in the release. “Our goal has always been to increase access to these treatments by onboarding more pharmacies to maximize access to patients.”
In Tennessee, the antiviral pills are available by prescription only at designated Walmart pharmacies, which are listed on the website covid19.tn.gov/oral-antiviral-treatments.
“We have seen a steady increase in allocations to the state and know many pharmacies and providers are eager to offer this treatment to help mitigate COVID-19 disease progression for those at risk of a severe outcome,” Piercey said.
